Facial hyperpigmentation: causes and treatment

Br J Dermatol. 2013 Oct:169 Suppl 3:41-56. doi: 10.1111/bjd.12536.

Abstract

By midcentury, the U.S.A. will be more ethnically and racially diverse. Skin of colour will soon constitute nearly one-half of the U.S. population, and a full understanding of skin conditions that affect this group is of great importance. Structural and functional differences in the skin, as well as the influence of cultural practices, produce variances in skin disease and presentation based on skin type. In the skin of colour population, dyschromia is a growing concern, and a top chief complaint when patients present to the physician. A thorough understanding of the aetiology and management strategies of facial hyperpigmentation is of importance in caring for those afflicted and also in the development of new therapies.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Alphavirus Infections / complications
  • Alphavirus Infections / ethnology
  • Chikungunya Fever
  • Dermabrasion / methods
  • Dermatologic Agents / therapeutic use
  • Drug Combinations
  • Facial Dermatoses / ethnology
  • Facial Dermatoses / etiology*
  • Facial Dermatoses / therapy
  • Humans
  • Hyperpigmentation / ethnology
  • Hyperpigmentation / etiology*
  • Hyperpigmentation / therapy
  • Laser Therapy / methods
  • Lichen Planus / complications
  • Lichen Planus / ethnology
  • Lichen Planus / therapy
  • Nevus / complications
  • Nevus / ethnology
  • Nevus / therapy
  • Ochronosis / complications
  • Ochronosis / ethnology
  • Ochronosis / therapy
  • Skin Neoplasms / complications
  • Skin Neoplasms / ethnology
  • Skin Neoplasms / therapy

Substances

  • Dermatologic Agents
  • Drug Combinations